INS and diabetes mellitus: Studies have demonstrated that visfatin could promote insulin and pro-inflammatory cytokines secretions [5, 14], and it is a pleiotropic protein implicated in the pathophysiology of obesity, metabolic disease, diabetes and cancer [15–18].